LOCALLY ADVANCED RENAL PELVIS CARCINOMA

Clinical trials for LOCALLY ADVANCED RENAL PELVIS CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new LOCALLY ADVANCED RENAL PELVIS CARCINOMA trials appear

Sign up with your email to follow new studies for LOCALLY ADVANCED RENAL PELVIS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New cancer combo aims to supercharge immune system while taming side effects

Disease control Ongoing

This study is testing a combination of three immunotherapy drugs—tocilizumab, ipilimumab, and nivolumab—in patients with advanced melanoma, non-small cell lung cancer, or bladder cancer. The main goal is to see if adding tocilizumab can help manage the serious side effects someti…

Matched conditions: LOCALLY ADVANCED RENAL PELVIS CARCINOMA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 16, 2026 15:26 UTC

LOCALLY ADVANCED RENAL PELVIS CARCINOMA

Get alerted when new LOCALLY ADVANCED RENAL PELVIS CARCINOMA trials appear

New cancer combo aims to supercharge immune system while taming side effects